Patient Guide: A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 122 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06140836
Status: ACTIVE_NOT_RECRUITING
Condition: Carcinoma, Non-Small-Cell Lung
Phase: PHASE3

Where You Can Participate

This study is available at 122 locations across the country.

Top locations include:
  • • Des Moines, Iowa
  • • Boston, Massachusetts
  • • Boston, Massachusetts
  • • And 119 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3) - Join Clinical Trial NCTNCT06140836

How to Join This Clinical Trial - NCTNCT06140836

Learn how to participate in this PHASE3 trial studying an investigational therapy for Carcinoma, Non-Small-Cell Lung. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Carcinoma, Non-Small-Cell Lung. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Carcinoma, Non-Small-Cell Lung
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06140836 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 122 locations. Find a study site near you:

Clinical Research Site

Des Moines, Iowa 50309 - United States

Status: Contact for availability

Clinical Research Site

Boston, Massachusetts 02114 - United States

Status: Contact for availability

Clinical Research Site

Boston, Massachusetts 02215 - United States

Status: Contact for availability

Clinical Research Site

Mineola, New York 11501 - United States

Status: Contact for availability

Clinical Research Site

New York, New York 10016 - United States

Status: Contact for availability

Clinical Research Site

Tacoma, Washington 98405 - United States

Status: Contact for availability

Clinical Research Site

Ciudad Autónoma de Buenos Aires, Buenos Aires 1280 - Argentina

Status: Contact for availability

Clinical Research Site

Ciudad Autónoma de Buenos Aires, Buenos Aires C1426ANZ - Argentina

Status: Contact for availability

Clinical Research Site

ABB, Buenos Aires F.D. C1199ABB - Argentina

Status: Contact for availability

Clinical Research Site

Buenos Aires, 1431 - Argentina

Status: Contact for availability

And 112 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Carcinoma, Non-Small-Cell Lung:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships